Optimising the duration of adjuvant trastuzumab in early breast cancer in the UK

MLA

Maggie Wilcox, et al. Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK. Jan. 2021. EBSCOhost, https://doi.org/10.1016/j.clon.2020.07.006.

APA

Maggie Wilcox, Luke Hughes-Davies, Peter Hall, David Cameron, Jean Abraham, Daniel Rea, Iain R. Macpherson, E. O’Riordan, Helena M. Earl, Carlos Caldas, Sophie Gasson, Andrew M Wardley, Duncan Wheatley, David Miles, Janine Mansi, Louise Hiller, Janet A. Dunn, & Karen McAdam. (2021). Optimising the duration of adjuvant trastuzumab in early breast cancer in the UK. https://doi.org/10.1016/j.clon.2020.07.006

Chicago

Maggie Wilcox, Luke Hughes-Davies, Peter Hall, David Cameron, Jean Abraham, Daniel Rea, Iain R. Macpherson, et al. 2021. “Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK,” January. doi:10.1016/j.clon.2020.07.006.